The Inflammatory Cytokine Profile Associated With Liver Damage Is Broader and Stronger in Patients With Chronic Hepatitis B Compared to Patients With Acute Hepatitis B

Abstract Liver damage in hepatitis B is immune driven and correlates with inflammatory markers in patient serum. There is no comparison of these markers to determine if inflammatory profiles are distinct to different types of liver damage across patients at different stages of disease. We measured 2...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases 2022-02, Vol.225 (3), p.470-475
Main Authors: Johnson Valiente, Alexandra, Liem, Kin Seng, Schwarz, Kathleen B, Rosenthal, Philip, Murray, Karen F, Mogul, Douglas, Teckman, Jeffery, Rodriguez-Baez, Norberto, Schwarzenberg, Sarah Jane, Feld, Jordan J, Wong, David K, Lewis-Ximenez, Lia L, Lauer, Georg, Hansen, Bettina E, Ling, Simon C, Janssen, Harry L A, Gehring, Adam J
Format: Article
Language:English
Subjects:
Cytotoxicity
FasL protein
Hepatitis
Hepatitis B
Hepatitis B e antigen
Interferon
Liver
Nucleoside analogs
Seroconversion
TRAIL protein
Tumor necrosis factor-α
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Liver damage in hepatitis B is immune driven and correlates with inflammatory markers in patient serum. There is no comparison of these markers to determine if inflammatory profiles are distinct to different types of liver damage across patients at different stages of disease. We measured 25 inflammatory markers in patients with acute hepatitis B and chronic hepatitis B with hepatitis B e antigen seroconversion and chronic patients stopping nucleoside analogue therapy. Myeloid markers dominated the inflammatory profile in all stages of hepatitis B. More inflammatory markers were detectable in chronic patients, including elevated concentrations of cytotoxic effectors Fas ligand, TRAIL, and TNF-α. The myeloid marker CD163 dominated the inflammatory profile across liver damage associated with different stages of hepatitis B virus infection. While profiles overlapped substantially, chemokines and cytotoxic effector molecules were elevated in chronic hepatitis B patients with liver damage.
ISSN:0022-1899
1537-6613
DOI:10.1093/infdis/jiab373